about
Ticks associated with macquarie island penguins carry arboviruses from four generaInfectious Chikungunya Virus in the Saliva of Mice, Monkeys and HumansChikungunya disease in nonhuman primates involves long-term viral persistence in macrophagesHuman Sin1 contains Ras-binding and pleckstrin homology domains and suppresses Ras signallingChikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signalingInterferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shockPhase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosisInhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motifMultiple immune factors are involved in controlling acute and chronic chikungunya virus infectionCCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritisKunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity.Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine DevelopmentThe role of SerpinB2 in immunityA neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from diseaseRNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammationDe Novo Generation and Characterization of New Zika Virus Isolate Using Sequence Data from a Microcephaly Case.Chikungunya virus, risks and responses for Australia.Potent inhibition of HIV-1 replication by a Tat mutant.Silencing of integrated human papillomavirus type 18 oncogene transcription in cells expressing SerpinB2.Tattoo removal with ingenol mebutate.Tumor cell-expressed SerpinB2 is present on microparticles and inhibits metastasis.Human papillomavirus E7 requires the protease calpain to degrade the retinoblastoma protein.Chikungunya virus arthritis in adult wild-type mice.Arthritogenic alphaviruses--an overview.Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses.Circulating heat shock protein 60 levels are elevated in HIV patients and are reduced by anti-retroviral therapyIncrease in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein.Tetracycline-inducible packaging cell line for production of flavivirus replicon particlesInduction of SerpinB2 and Th1/Th2 modulation by SerpinB2 during lentiviral infections in vivoEffective chikungunya virus-like particle vaccine produced in insect cells.A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritisMacrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus.Identification and characterization of a ross river virus variant that grows persistently in macrophages, shows altered disease kinetics in a mouse model, and exhibits resistance to type I interferonSuppression of antiviral responses by antibody-dependent enhancement of macrophage infection.Polytope vaccines for the codelivery of multiple CD8 T-cell epitopes.SerpinB2 (PAI-2) Modulates Proteostasis via Binding Misfolded Proteins and Promotion of Cytoprotective Inclusion Formation.IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.A Kunjin Replicon Virus-like Particle Vaccine Provides Protection Against Ebola Virus Infection in Nonhuman Primates.From mice to humans - murine intelligence for human CD8+ T cell vaccine design.Ross River virus: molecular and cellular aspects of disease pathogenesis.
P50
Q21092148-6326E315-94A4-4CD1-A888-57417B5C6CF5Q24288650-39777324-AA46-404C-8108-208311CD4275Q24288996-7AF0684A-94BE-4A1E-9DF4-A3E853F5B82CQ24297405-63F62BCB-2511-47D4-8235-26313FC85A55Q24594497-C19A4EF6-9BC9-4F98-9FE2-D61CD2804499Q24598171-8C2FF80F-72ED-4A4B-A8C5-1302D80022C6Q24657081-521EC89F-6C60-48C3-B396-C58320295048Q24682801-DF9E9723-782E-4E7A-9A73-DE159234E5DFQ24701792-9307AB1D-2347-469C-A25F-F27F5EA3854EQ24701793-44E6EC31-503C-4BB7-AAEE-AE50F26791F9Q27472866-0CFFC20A-2EA8-49DD-ADB3-C8B4B0939C9FQ27477561-B64E1417-A9F5-426C-81CF-D5F259E133D9Q28307084-05D44618-EC7A-4B3D-90A3-80A410A4618FQ28533408-A0D1262A-04E5-471B-99D8-5AF89727B3DCQ28804081-AEF3ABF5-F90B-4447-B313-43423443AB54Q30145584-E27A84F2-1982-48CE-8D20-0D6ECADC4AB7Q30386252-F1F22C5E-0B0F-41A4-BCC2-B6F9CE9FD450Q30879123-EFBD748B-1784-4153-91AD-344F4187FE3EQ33707512-ED16E575-C727-4946-8179-41B2A8E5A701Q33739024-6D085820-1CF2-4070-8C61-3FCC3934F6F8Q33913517-3B6F821D-4354-4B86-AFA7-CF58E8D6358DQ34007987-A6C96389-139A-43BE-82ED-A54258B1EBDAQ34046030-09B47647-9A7E-4982-9000-3F4B2F056D27Q34273343-BA85863E-3DA2-46FF-8772-E5EB9AD6A52DQ34327466-F8ADB0D6-224B-4C64-BC7A-C080A0BAEEB8Q34428634-5D207E0B-9CFA-4452-8FCE-5F9CF056A649Q34511631-93D84AD2-11CF-4333-BEF9-38665F3138A0Q34552578-40147E5A-D933-4109-ADA4-7D091F888625Q34608495-1BACD083-47C0-430D-B2FD-86EE7E01B190Q34630576-85968644-94B0-4467-A86E-D6124ED6EE21Q34703785-85BF5E89-223C-428E-A152-8DDE5FEC1BD9Q34773767-A697FAEF-A611-4BEF-9A69-946EEE9869B2Q34982662-B2FCE3A6-AF8B-4B71-9F78-7EADF4EEA4B9Q35107882-C6460A34-0A15-46AB-A5BE-6BB774B72FFFQ35193438-63AFDA67-69E6-42E5-A058-21A22AD8F534Q35666031-759CFE36-A047-43F6-AD1A-90D1A469E67AQ35996041-50AEF432-186C-4C73-946B-F51EC9F91B0BQ36043170-B6A8F05F-8F94-4019-86A4-66D0FE25F746Q36065972-ED3535CA-04C0-4E6D-B570-CDD0500F962AQ36143487-BB9D51D7-507E-453F-826A-C72DD5C4991D
P50
description
researcher ORCID ID = 0000-0001-8986-9025
@en
wetenschapper
@nl
name
Andreas Suhrbier
@ast
Andreas Suhrbier
@en
Andreas Suhrbier
@es
Andreas Suhrbier
@nl
type
label
Andreas Suhrbier
@ast
Andreas Suhrbier
@en
Andreas Suhrbier
@es
Andreas Suhrbier
@nl
prefLabel
Andreas Suhrbier
@ast
Andreas Suhrbier
@en
Andreas Suhrbier
@es
Andreas Suhrbier
@nl
P21
P31
P496
0000-0001-8986-9025